Authorized purpose: Opportunistic review of frontal lumbar-spine or KUB radiographs in adults aged 50 years and older to flag possible low bone mineral density at L1-L4 for clinician follow-up; a negative result does not rule out low BMD.
Clinical role
Generates a notification report only for positive cases of possible low BMD at L1–L4, with a vertebral ROI overlay for clinician verification, to prompt bone-health assessment; negatives produce no output, and it is not for ruling out low BMD.
Images and patients
X-ray/Radiography · Spine/Bone Health
Key limitation
Keep in mind: Exclusion criteria: Images in which one or more L1-L4 vertebrae contains: (a) metallic spinal implants or prostheses (e.g., pedicle screws, rods, cages, or total disc replacements); (b) vertebral cement augmentation (e.g., kyphoplasty or vertebroplasty); (c) severe vertebral deformity, fracture, or other structural abnormality that would preclude a valid DXA-based L1-L4 BMD measurement; or (d) extraspinal medical implants overlying the L1-L4 measurement region (e.g., abdominal aortic stent grafts or vascular grafts).
Clinical detailsPurpose, workflow fit, evidence, and safety record
Workflow navigation pilot
Workflow role has not yet been reviewed for this navigation pilot.
A tag identifies a documented role; it does not establish compatibility or local acceptance. Methods and sources
What does this software do?Authorized purpose: Opportunistic review of frontal lumbar-spine or KUB radiographs in adults aged 50 years and older to flag possible low bone mineral density at L1-L4 for clinician follow-up; a negative result does not rule out low BMD.
Which images or clinical context are in scope?Modality: X-ray/Radiography Anatomy or clinical context: Spine/Bone Health Input: DeepXray Spina is intended for use with standard frontal radiographs of the lumbar spine or KUB that are suitable for L1–L4 BMD analysis.
Who uses it?Intended users: Radiologists and/or physician interpreters
What does the software produce?Output: The device outputs a binary classification: 'Low BMD' (internal L1-L4 T-score 2.5) or 'Not Suspected' (internal L1-L4 T-score > 2.5). A DeepXray Spina report is generated for positive cases only, displaying a vertebral region-of-interest (ROI) overlay on the original radiograph. For negative results, no report is generated. An automated Quality-Control (QC) function detects technical and anatomical exclusion conditions and flags input images with potential quality issues.
What is its most important limitation?Key limitation: Exclusion criteria: Images in which one or more L1-L4 vertebrae contains: (a) metallic spinal implants or prostheses (e.g., pedicle screws, rods, cages, or total disc replacements); (b) vertebral cement augmentation (e.g., kyphoplasty or vertebroplasty); (c) severe vertebral deformity, fracture, or other structural abnormality that would preclude a valid DXA-based L1-L4 BMD measurement; or (d) extraspinal medical implants overlying the L1-L4 measurement region (e.g., abdominal aortic stent grafts or vascular grafts).
Clinical takeaway. Clinical role: Opportunistic review of frontal lumbar-spine or KUB radiographs in adults aged 50 years and older to flag possible low bone mineral density at L1-L4 for clinician follow-up; a negative result does not rule out low BMD.
Evidence takeaway. Evidence from the reviewed source record: Study type: Stand-Alone Performance. Cases: 1219. Reported sensitivity: 77.0% (95% CI: 72.0%, 81.9%). Reported specificity: 93.6% (95% CI: 92.1%, 95.1%)
Evidence context
Evidence context not reviewed for this FDA record.
Public-label constraints
Label constraints have not been reviewed for this exact FDA record. Unknown is not all ages or evidence of unsuitability.
Public-label constraints, not patient-level eligibility or a medical recommendation. Training and evaluation populations are separate. Read the original labeling and confirm the exact release and protocol.
Purpose
Opportunistic review of frontal lumbar-spine or KUB radiographs in adults aged 50 years and older to flag possible low bone mineral density at L1-L4 for clinician follow-up; a negative result does not rule out low BMD.
Generates a notification report only for positive cases of possible low BMD at L1–L4, with a vertebral ROI overlay for clinician verification, to prompt bone-health assessment; negatives produce no output, and it is not for ruling out low BMD.
Exact FDA submission
Checked 2026-11-14
Packet wording: "A DeepXray Spina report is generated for positive cases. For cases where the algorithm outputs a negative result, no report is generated, and neither the radiologist nor the referring physician receives any device output." … "Each generated report displays a vertebral region-of-interest (ROI) overlay on the original radiograph, enabling the clinician to visually verify anatomical localization and the absence of severe artifacts before acting on the result.". Read from the exact FDA decision document on 2026-11-14.
DeepXray Spina is intended for use with standard frontal radiographs of the lumbar spine or KUB that are suitable for L1–L4 BMD analysis.
Exact FDA submission
Checked 2026-09-19
The exact input restriction states the supported frontal lumbar-spine or KUB radiographs and suitability for L1–L4 BMD analysis; the current generic consultation wording is not packet text.
The device outputs a binary classification: 'Low BMD' (internal L1-L4 T-score 2.5) or 'Not Suspected' (internal L1-L4 T-score > 2.5). A DeepXray Spina report is generated for positive cases only, displaying a vertebral region-of-interest (ROI) overlay on the original radiograph. For negative results, no report is generated. An automated Quality-Control (QC) function detects technical and anatomical exclusion conditions and flags input images with potential quality issues.
Exact FDA submission
Checked 2026-09-19
Exact FDA decision-summary packet reviewed on 2026-09-19; existing wording is supported without expansion.
Exclusion criteria: Images in which one or more L1-L4 vertebrae contains: (a) metallic spinal implants or prostheses (e.g., pedicle screws, rods, cages, or total disc replacements); (b) vertebral cement augmentation (e.g., kyphoplasty or vertebroplasty); (c) severe vertebral deformity, fracture, or other structural abnormality that would preclude a valid DXA-based L1-L4 BMD measurement; or (d) extraspinal medical implants overlying the L1-L4 measurement region (e.g., abdominal aortic stent grafts or vascular grafts).
Exact FDA submission
Checked 2026-09-19
Exact FDA decision-summary packet reviewed on 2026-09-19; existing wording is supported without expansion.
Metrics are shown only when they are tied to a source, endpoint, population, and tested product version. Candidate literature without exact product and version linkage is not shown as product evidence.
No contextualized exact-version metric has completed evidence review. Regulatory-document values, when available, are shown above with their limitations.
DeepXray Spina regulatory performance study summary
DesignStand-Alone Performance
PopulationAdult
Scopeexact submission
Tested versionExact product version not reported; regulatory study summarized for FDA submission K253192
Samplen=1219
IndependenceIndependence not established
K253192
ACR AI Central summarizes the regulatory study; consult the exact FDA materials before comparative use.
Recall and adverse-event records are shown only after product matching. Adverse-event reports do not establish incidence or causality.
Postmarket safety review
The exact-identifier FDA recall query returned no native recall record for K253192. This limited result does not establish absence of recalls or other safety information and does not cover later versions, family records, MAUDE reports, corrections, or field notices.
IT implementationDeployment, interfaces, data handling, and support
System and version relationships
Match the AI release, system build, configuration and region. Source documentation does not establish acceptance of an installed system.
No specific system/version pairing has completed review for this FDA record. A broad DICOM or product-family statement does not establish a named viewer build's support.
Public source context, not tested interoperability. Each hop needs its own release/configuration evidence. Missing or unavailable routes are not documented incompatibility. All local tests are planned, not passed; no installed-system acceptance is recorded.
Acquisition/source → routing → AI processing → returned objects → viewer/worklist/report → support owner
No specific route context has been source-reviewed for this record. Obtain both endpoint builds and documents; this is not a finding of incompatibility.
Acquisition/source
Source context, not route validation: DeepXray Spina is intended for use with standard frontal radiographs of the lumbar spine or KUB that are suitable for L1–L4 BMD analysis.
Scope: Exact FDA submission. The exact input restriction states the supported frontal lumbar-spine or KUB radiographs and suitability for L1–L4 BMD analysis; the current generic consultation wording is not packet text.
Confirm scanner/model, protocol, series completeness and both software builds.
Source context, not route validation: The exact FDA package describes an add-on module to the DeepXray system, run in Docker containers on a Linux server in the institution's local network, whose Input & Report Server manages DICOM inputs and returns a web-based browser report or a DICOM-format report to PACS. Interface versions and local compatibility require confirmation.
Scope: Exact FDA submission. Packet wording: "DeepXray Spina is installed as an add-on module to the cleared DeepXray system (K223621). The software is deployed within Docker containers on a Linux server inside the institution’s local network and shares the same Input & Report Server (IRS) as DeepXray." … "The IRS manages DICOM inputs, performs basic tag and image-type filtering, and delivers outputs through either a web-based report accessible from a browser or a static DICOM-format report returned to the institution’s PACS.". Read from the exact FDA decision document on 2026-11-14.
Name gateways, destinations, transfer rules and failure visibility; a DICOM statement does not prove a route.
Unresolved route: Not established for the exact route.
Scope: Exact FDA submission. The reviewed sources do not establish the current exact-release hosting topology, data flow, region, tenancy, or disaster-recovery configuration.
Confirm processing location, queue ownership, exclusions and exact AI build.
Field checked 2026-09-08 ·
Returned objects
Source context, not route validation: The device outputs a binary classification: 'Low BMD' (internal L1-L4 T-score 2.5) or 'Not Suspected' (internal L1-L4 T-score > 2.5). A DeepXray Spina report is generated for positive cases only, displaying a vertebral region-of-interest (ROI) overlay on the original radiograph. For negative results, no report is generated. An automated Quality-Control (QC) function detects technical and anatomical exclusion conditions and flags input images with potential quality issues.
Scope: Exact FDA submission. Exact FDA decision-summary packet reviewed on 2026-09-19; existing wording is supported without expansion.
Confirm object classes, units, references and whether findings, overlays or measurements reach their intended destination.
Unresolved route: The device outputs a binary classification: 'Low BMD' (internal L1-L4 T-score 2.5) or 'Not Suspected' (internal L1-L4 T-score > 2.5). A DeepXray Spina report is generated for positive cases only, displaying a vertebral region-of-interest (ROI) overlay on the original radiograph. For negative results, no report is generated. An automated Quality-Control (QC) function detects technical and anatomical exclusion conditions and flags input images with potential quality issues.
Scope: Exact FDA submission. Exact FDA decision-summary packet reviewed on 2026-09-19; existing wording is supported without expansion.
Confirm the named viewer/worklist/report build, display behavior and report transfer. Output support alone does not establish this endpoint. The displayed source describes output, not validated end-to-end delivery.
Unresolved route: Not established for the exact route.
Scope: Scope not established.
Name the local, platform and AI supplier support owners and escalation path.
Planned local route tests
No tests below have been performed or accepted.
Patient/study identity (planned). Use approved non-patient test data to verify identifiers, accession and result-to-study linkage at every hop.
Study completeness (planned). Test missing views/series, partial transfer, late arrivals, priors and unsupported acquisition inputs; confirm explicit refusal or fallback.
Ordering and duplicates (planned). Send out-of-order, repeated and corrected studies; verify worklist order, deduplication and no misleading stale results.
Report transfer (planned). Verify output object types, annotations, units, report content, destination and availability of original images.
Access (planned). Verify authorized roles, audit trail, denied access and support ownership at each destination.
Latency and failures (planned). Agree a workload and turnaround target; test queues, timeouts, missing results and fallback reading.
Updates and rollback (planned). Define version change control, revalidation triggers, stop-use criteria and a tested rollback route.
Local implementation checklist
Agree the evidence and acceptance owner with your team and suppliers. Checkmarks apply to this page only and are not acceptance receipts.
The exact FDA package describes an add-on module to the DeepXray system, run in Docker containers on a Linux server in the institution's local network, whose Input & Report Server manages DICOM inputs and returns a web-based browser report or a DICOM-format report to PACS. Interface versions and local compatibility require confirmation.
Exact FDA submission
Checked 2026-11-14
Packet wording: "DeepXray Spina is installed as an add-on module to the cleared DeepXray system (K223621). The software is deployed within Docker containers on a Linux server inside the institution’s local network and shares the same Input & Report Server (IRS) as DeepXray." … "The IRS manages DICOM inputs, performs basic tag and image-type filtering, and delivers outputs through either a web-based report accessible from a browser or a static DICOM-format report returned to the institution’s PACS.". Read from the exact FDA decision document on 2026-11-14.
ACR AI Central provides an exact-submission model card for DeepXray Spina; FDA labeling remains controlling for clinical use, limitations, and performance.
Sources & review detailsFDA identity, research record, source ledger, and history
Regulatory identity
FDA record and catalog context
The FDA listing establishes the regulatory identity. It does not by itself establish local workflow fit, pricing, security, or performance in your environment.
This audit distinguishes completed source review from fields that have not yet been researched.
Exact FDA record reviewedStatus
2026-09-20Last searched
25Fields reviewed
10Source classes checked
2Screened PubMed leads
0Screened trial leads
0Unreviewed FDA recall leads
The refreshed discovery snapshot contains 2 PubMed and 0 ClinicalTrials.gov candidate records. Discovery metadata alone does not establish exact tested-product, version, population, and endpoint applicability, so all candidates remain quarantined and none was promoted. The current discovery snapshot contains 2 PubMed and 0 ClinicalTrials.gov candidate records; its dated, count-matched human screening remains current. Unlinked candidates remain quarantined. Native FDA recall identifiers produced 0 postmarket candidate records; 0 have been reviewed (0 published, 0 rejected) and 0 remain unreviewed.
Candidate leads were screened against the exact product and tested version. Unlinked records remain quarantined.
Source classes: fda ai list, acr ai central product, fda decision summary, fda device recall, literature index, trial registry, fda decision summary packet, pubmed, clinical trials, openfda device recall
Field review details
Recorded state, verification date, notes and sources for fields without a publishable value. Conflicting records stay explicitly unsettled here; no plain settled value is shown for them.
Public pricing: Not verified - checked 2026-09-08 - Exact FDA submission
No public price or quote for the exact K253192 configuration was established in this review.
Pricing model: Not yet reviewed
Setup and integration fees: Not yet reviewed
Recurring fees: Not yet reviewed
Minimum commitment: Not yet reviewed
Contract duration: Not yet reviewed
Renewal terms: Not yet reviewed
Cancellation terms: Not yet reviewed
Support and service terms: Not yet reviewed
Trial or pilot terms: Not yet reviewed
Reimbursement: Not publicly available - checked 2026-09-08 - Exact FDA submission
No exact-product payer policy, coding instruction, or payment determination was established; eligibility must be evaluated by payer, site of service, and use case.
Deployment: Not verified - checked 2026-09-08 - Exact FDA submission
The reviewed sources do not establish the current exact-release hosting topology, data flow, region, tenancy, or disaster-recovery configuration.
Data hosting location: Not yet reviewed
Data retention: Not yet reviewed
Documented data use: Not yet reviewed
Hardware requirements: Not yet reviewed
Network requirements: Not yet reviewed
Identity and access: Not yet reviewed
Security: Not verified - checked 2026-09-08 - Exact FDA submission
Exact-release security controls, data retention, hosting boundaries, and scoped assurance documentation require vendor confirmation.
Installation timeline: Not yet reviewed
Training: Not verified - checked 2026-09-08 - Exact FDA submission
Current training prerequisites, competency checks, and support commitments for the exact configuration require vendor confirmation.
Monitoring: Not verified - checked 2026-09-08 - Exact FDA submission
Current drift, quality, uptime, alert, escalation, and incident-response commitments for the exact configuration require vendor confirmation.
Authorized purpose: Rayvolve supports clinicians by identifying suspected fractures, joint effusions, and dislocations on labeled radiographic views; it does not replace clinician interpretation.
Modality
X-ray/Radiography
Anatomy
Musculoskeletal and chest/ribs radiographs across specified views
Authorized purpose: Concurrent-read CADe to assist dentists in detecting specified tooth and jaw anatomy, bone-level landmarks, and root-canal-treated teeth in digital radiographs of permanent teeth in patients 15 years or older.
Modality
X-ray/Radiography
Anatomy
Permanent teeth and jaw/maxillofacial anatomy, including enamel, dentine, pulp, root, mental foramen, inferior alveolar canal, maxillary sinus, cementoenamel junction, crestal bone, and root-canal-treated teeth
Authorized purpose: qXR-Detect is an adult chest-radiograph concurrent reading aid that identifies, highlights and categorizes suspicious regions of interest across lung, pleura, mediastinum/hila/heart, bone, hardware and other categories; trained clinicians remain responsible for primary interpretation.
Modality
X-ray/Radiography
Anatomy
Chest/Lung; pleura, mediastinum/hila/heart, bone, hardware and other chest-radiograph regions
Authorized purpose: View and quantify bone age from 2D posteroanterior left-hand radiographs to aid pediatric radiologists assessing patients aged 2-18 years.
Copy this public context and add the field, proposed wording and original source before sending. Nothing here is submitted automatically. Form-specific prefill has not been verified.
Permission to display a submission is not evidence verification. A submission enters editorial review; it does not approve a public change. Form availability, data entry, receipt, review and publication are separate steps. Data entry and receipt remain unverified.
Accepted repository change history
No entry has been added to this scoped change history for this record. This is not proof that the record never changed.